4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000950170-25-030181
Director bought 7,000 shares at $44.85 ($313,948)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Greene John Director | 2025-02-26 | Purchase | +7,000 | $44.85 | $313,948 | 7,000 | D: show line 1 in the form |
| Open-market purchases · 7,000 sh · avg $44.85 · $313,948 | |||||||
Loading xslF345X05/ownership.xml…